Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Commodore Capital LP's stake in Terns Pharmaceuticals, Inc. fell to 1.40% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Commodore Capital LP's stake in Terns Pharmaceuticals, Inc. fell to 1.40%, 1,475,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 1.40%
- Shares
- 1,475,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 1.40% | 1,475,000 |
| Commodore Capital Master LP | 1.40% | 1,475,000 |
| Robert Egen Atkinson | 1.40% | 1,475,000 |
| Michael Kramarz | 1.40% | 1,475,000 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Commodore Capital LP
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Nov 14, 2025
- Schedule 13G · Commodore Capital LP · Sep 16, 2025
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026